Insider Stock Trading History of Ramsay David A


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Ramsay David A since year 2005. The trader's CIK number is 1283292. At the time of this reporting, Ramsay David A is the Director of Adventrx Pharmaceuticals Inc . (stock ticker symbol ANX). See this page for all insider trading activities at Adventrx Pharmaceuticals Inc .

Note that in the past RAMSAY DAVID A also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Ramsay David A since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-06-07 SVRA Adventrx Pharmaceuticals Inc Buy 21,000 4.75 99,750
2015-02-06 HALO Halozyme Therapeutics Inc Option Ex 7,088 .00 0
2015-02-04 HALO Halozyme Therapeutics Inc Option Ex 2,213 .00 0
2015-02-02 HALO Halozyme Therapeutics Inc Option Ex 3,125 .00 0
2014-12-22 HALO Halozyme Therapeutics Inc Option Ex 17,625 .00 0
2014-12-01 HALO Halozyme Therapeutics Inc Option Ex 20,058 2.02 40,517
2014-09-16 HALO Halozyme Therapeutics Inc Buy 25,000 8.90 222,500
2014-09-16 HALO Halozyme Therapeutics Inc Option Ex 50,000 2.05 102,499
2014-02-02 HALO Halozyme Therapeutics Inc Option Ex 3,125 .00 0
2014-02-04 HALO Halozyme Therapeutics Inc Option Ex 2,213 .00 0
2013-12-20 HALO Halozyme Therapeutics Inc Option Ex 6,419 .00 0
2013-09-16 HALO Halozyme Therapeutics Inc Option Ex 130,000 .39 50,700
2012-05-14 ANX Adventrx Pharmaceuticals Inc Buy 50,000 .54 26,950
2012-05-09 ANX Adventrx Pharmaceuticals Inc Buy 10,000 .55 5,500
2012-05-10 ANX Adventrx Pharmaceuticals Inc Buy 40,000 .56 22,599
2008-03-18 HALO Halozyme Therapeutics Inc Buy 10,000 4.55 45,500
2007-07-26 HALO Halozyme Therapeutics Inc Option Ex 30,000 .39 11,700
2007-07-16 HALO Halozyme Therapeutics Inc Sale 10,000 9.89 98,880
2007-06-14 HALO Halozyme Therapeutics Inc Sale 10,000 10.12 101,240
2007-05-14 HTI Halozyme Therapeutics Inc Sale 10,000 10.19 101,900
2005-08-24 HTI Halozyme Therapeutics Inc Buy 10,000 1.70 17,000
2005-08-23 HTI Halozyme Therapeutics Inc Buy 5,000 1.69 8,425
2005-05-27 HTI Halozyme Therapeutics Inc Buy 10,000 1.99 19,900

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ramsay David A (Director of Adventrx Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.